{"0.00":{"start":"0","dur":"7","text":"Translator: Gianna Carroni\nReviewer: Denise RQ"},"8.73":{"start":"8.727","dur":"5.508","text":"Zika virus, dengue fever, chikungunya -"},"15.60":{"start":"15.596","dur":"4.761","text":"these diseases, which are\nall spread by the Aedes mosquito,"},"20.36":{"start":"20.358","dur":"3.509","text":"afflict millions of people\naround the world."},"24.51":{"start":"24.507","dur":"3.521","text":"Very recently,\nthe World Health Organization"},"28.03":{"start":"28.029","dur":"2.784","text":"for only the fourth time in its history,"},"31.57":{"start":"31.569","dur":"5.261","text":"declared the current Zika outbreak\nas a global public health emergency."},"37.86":{"start":"37.861","dur":"4.199","text":"Although these diseases\nhave been known for decades,"},"43.32":{"start":"43.32","dur":"4.025","text":"no drug has ever been developed\nto treat any of them."},"48.12":{"start":"48.122","dur":"1.14","text":"Why?"},"50.29":{"start":"50.291","dur":"3.78","text":"Putting it simply,\ntheir markets are too small."},"54.07":{"start":"54.072","dur":"2.34","text":"The cold heart truth"},"56.41":{"start":"56.413","dur":"6.068","text":"is that it can cost billions of dollars\nand take decades to develop a new drug."},"62.82":{"start":"62.824","dur":"4.309","text":"So, pharmaceutical companies,\nalmost invariably,"},"67.13":{"start":"67.134","dur":"5.261","text":"only pursue drugs for diseases\nthat will generate large profits."},"73.56":{"start":"73.555","dur":"6.86","text":"Unfortunately, this system is ill-suited\nfor diseases that primarily afflict"},"80.42":{"start":"80.416","dur":"4.472","text":"the poor of the world,\nthe so-called neglected diseases."},"86.82":{"start":"86.817","dur":"5.061","text":"The Centers for Disease Control in Atlanta\nestimate that annually"},"92.40":{"start":"92.398","dur":"5.532","text":"three billion people worldwide are at risk\nfor contracting a neglected disease;"},"98.74":{"start":"98.738","dur":"4.682","text":"and of them, more than a half million\nwill die each year."},"104.19":{"start":"104.189","dur":"4.942","text":"So just imagine\nthe humanitarian impact we could have"},"109.48":{"start":"109.481","dur":"2.88","text":"if we could devise a viable system"},"112.36":{"start":"112.362","dur":"6.111","text":"for discovering and bringing to market\nnew drugs for neglected diseases."},"119.05":{"start":"119.054","dur":"5.07","text":"In 1990, when this picture\nof a young man dying of AIDS"},"124.13":{"start":"124.125","dur":"3.471","text":"appeared on the cover of Life magazine,"},"128.35":{"start":"128.346","dur":"1.978","text":"the virus was taking the lives"},"130.33":{"start":"130.326","dur":"4.29","text":"of some of our most creative\nand promising individuals."},"135.08":{"start":"135.078","dur":"3.868","text":"At that time, AIDS was a neglected disease"},"138.95":{"start":"138.947","dur":"3.741","text":"because infected patients\ndidn&#39;t survive long enough"},"142.69":{"start":"142.689","dur":"3.04","text":"to create a sustainable market."},"146.72":{"start":"146.72","dur":"1.438","text":"During that period,"},"148.16":{"start":"148.159","dur":"3.801","text":"I was an Organic Chemistry Professor\nat Emory University"},"151.96":{"start":"151.961","dur":"4.887","text":"and saw an opportunity to use\nmy skills and experience"},"156.87":{"start":"156.868","dur":"4.154","text":"to try to bring\nthis heartless killer under control."},"161.48":{"start":"161.475","dur":"2.636","text":"So I made it my personal goal"},"164.11":{"start":"164.112","dur":"3.531","text":"to create drugs that were so effective"},"167.95":{"start":"167.947","dur":"2.215","text":"that AIDS could be transformed"},"170.16":{"start":"170.163","dur":"4.85","text":"from a death sentence\nto a manageable disease."},"177.49":{"start":"177.493","dur":"5.859","text":"After some time, my lab was able\nto prepare some promising new compounds"},"183.35":{"start":"183.353","dur":"6.201","text":"and file our first US patent application\non them on February 1, 1990,"},"189.98":{"start":"189.975","dur":"5.2","text":"which, fortuitously,\nwas seven days ahead of our competition."},"197.08":{"start":"197.082","dur":"2.239","text":"This proved to be the critical step"},"199.32":{"start":"199.322","dur":"5.77","text":"in securing our rights to the drugs\nLamivudine and Emtricitabine,"},"205.51":{"start":"205.513","dur":"3.029","text":"both of which have\ndramatically transformed"},"208.54":{"start":"208.543","dur":"3.361","text":"how we treat HIV-infected patients."},"213.60":{"start":"213.603","dur":"1.163","text":"By the time"},"214.77":{"start":"214.767","dur":"4.449","text":"the first combination therapies\nfor AIDS came along in the mid 90s,"},"219.22":{"start":"219.217","dur":"6.21","text":"patients were required to take\n15 to 20 pills each day."},"225.74":{"start":"225.736","dur":"3.59","text":"Some before they ate, some after they ate."},"230.15":{"start":"230.146","dur":"2.77","text":"Due to the complexity of these regimens,"},"232.92":{"start":"232.917","dur":"4.85","text":"non-complying patients were at risk\nfor developing resistance."},"239.51":{"start":"239.508","dur":"2.398","text":"By 2006, however,"},"241.91":{"start":"241.907","dur":"2.868","text":"patients could take Atripla,"},"244.78":{"start":"244.776","dur":"4.709","text":"which combines three drugs,\none of which is Emtricitabine,"},"249.49":{"start":"249.486","dur":"2.853","text":"into a single daily dose."},"253.01":{"start":"253.005","dur":"4.203","text":"This regimen has proven\nto be so effective"},"257.21":{"start":"257.209","dur":"5.728","text":"that patients on it can live\nnearly normal lives for decades."},"264.16":{"start":"264.161","dur":"2.521","text":"In the US, we estimate"},"266.68":{"start":"266.683","dur":"5.999","text":"that over 90%\nof all HIV-infected patients on therapy"},"273.15":{"start":"273.152","dur":"3.511","text":"take or have taken our drug."},"277.06":{"start":"277.064","dur":"3.018","text":"This success, which is heartwarming,"},"280.08":{"start":"280.083","dur":"4.668","text":"also demonstrates\nthat drugs can come from sources"},"284.75":{"start":"284.752","dur":"2.552","text":"other than pharmaceutical companies."},"287.31":{"start":"287.305","dur":"2.132","text":"But there was a downside."},"290.62":{"start":"290.615","dur":"5.071","text":"It took 13 years to develop Emtricitabine."},"295.69":{"start":"295.687","dur":"1.878","text":"I&#39;ve often wondered"},"297.57":{"start":"297.566","dur":"3.845","text":"how many patients died during that time."},"301.41":{"start":"301.412","dur":"3.654","text":"Clearly, we needed\na better way to develop drugs;"},"305.07":{"start":"305.067","dur":"3.522","text":"especially drugs for neglected diseases."},"309.37":{"start":"309.368","dur":"3.03","text":"To do this, we have to find new ways"},"312.40":{"start":"312.399","dur":"3.619","text":"of catalyzing more research\nin these areas."},"316.02":{"start":"316.019","dur":"5.36","text":"One very innovative way\nis through networking organizations,"},"321.38":{"start":"321.38","dur":"2.338","text":"like WIPO Re: Search,"},"323.72":{"start":"323.719","dur":"5.621","text":"that match innovators\nwith potential partners,"},"329.34":{"start":"329.341","dur":"6.493","text":"and create a speed dating mechanism\nfor early-stage therapeutics development."},"336.83":{"start":"336.832","dur":"1.6","text":"Secondly,"},"338.80":{"start":"338.802","dur":"4.949","text":"we need to overcome a major funding gap\nin the development process"},"343.75":{"start":"343.752","dur":"2.546","text":"known as &#39;the valley of death, &#39;"},"346.30":{"start":"346.299","dur":"4.666","text":"where promising technologies\ncan wither and die,"},"350.97":{"start":"350.966","dur":"4.407","text":"due to insufficient infrastructures\nand resources."},"356.17":{"start":"356.171","dur":"1.74","text":"At present,"},"357.91":{"start":"357.912","dur":"6.229","text":"most neglected disease research\nis funded by philanthropy."},"364.14":{"start":"364.142","dur":"3.39","text":"But with just philanthropic funding,"},"367.53":{"start":"367.533","dur":"3.837","text":"it&#39;s hard to sustain\na development process"},"371.37":{"start":"371.371","dur":"3.252","text":"that can take a decade\nor more to complete."},"375.41":{"start":"375.41","dur":"2.477","text":"As one possible solution to this,"},"377.89":{"start":"377.888","dur":"4.664","text":"we invested some\nof our Emtricitabine patent royalties"},"382.55":{"start":"382.553","dur":"5.099","text":"into a small non-profit drug development\ncompany called DRIVE,"},"387.65":{"start":"387.653","dur":"3.395","text":"an acronym for Drug Innovation Ventures."},"391.05":{"start":"391.049","dur":"3.815","text":"DRIVE is led by a team\nof highly experienced scientists,"},"394.87":{"start":"394.865","dur":"3.999","text":"many of whom have previously\ndeveloped antiviral drugs."},"400.11":{"start":"400.106","dur":"3.869","text":"Without shareholders or investors,"},"403.98":{"start":"403.976","dur":"4.481","text":"DRIVE can focus\non the most critical unmet needs"},"409.06":{"start":"409.055","dur":"3.764","text":"rather than those that might\ngenerate the largest profits."},"414.83":{"start":"414.828","dur":"5.541","text":"DRIVE&#39;s focus is on\nsingle-stranded viral RNA infections."},"421.10":{"start":"421.099","dur":"7.311","text":"These infections, which have by and large\nonly modest commercial potential,"},"429.28":{"start":"429.28","dur":"4.11","text":"account for approximately 80%"},"433.39":{"start":"433.391","dur":"1.56","text":"- eight-zero -"},"434.95":{"start":"434.952","dur":"3.9","text":"of our worldwide viral disease burden."},"439.75":{"start":"439.752","dur":"3.41","text":"By pursuing a mixed portfolio"},"443.16":{"start":"443.163","dur":"3.055","text":"of major market and neglected diseases,"},"446.22":{"start":"446.219","dur":"2.259","text":"DRIVE was able to use revenues"},"448.48":{"start":"448.479","dur":"4.264","text":"obtained from the sale\nof a major market antiviral patent"},"452.74":{"start":"452.744","dur":"4.521","text":"to subsidize research\non neglected viral disease."},"457.90":{"start":"457.895","dur":"1.861","text":"Thanks to lessons learned,"},"460.31":{"start":"460.305","dur":"2.711","text":"this process only took 15 months,"},"463.02":{"start":"463.017","dur":"1.408","text":"which is notable,"},"464.43":{"start":"464.426","dur":"5.201","text":"since the comparable process\nfor Emtricitabine took four years."},"472.83":{"start":"472.826","dur":"5.741","text":"How can we translate\nDRIVE&#39;s proof of concept"},"479.53":{"start":"479.526","dur":"2.531","text":"into a worldwide framework"},"482.06":{"start":"482.058","dur":"5.261","text":"that will allow us to more rapidly address\nneglected diseases?"},"489.03":{"start":"489.027","dur":"4.18","text":"How can we, as a global community,"},"493.21":{"start":"493.208","dur":"3.219","text":"assemble the pieces necessary"},"496.43":{"start":"496.428","dur":"5.888","text":"to discover new drugs,\nto treat the diseases of the poor,"},"502.32":{"start":"502.317","dur":"5.207","text":"like Zika virus, like dengue fever,\nlike chikungunya?"},"509.97":{"start":"509.969","dur":"2.009","text":"Over the past 15 years,"},"511.98":{"start":"511.979","dur":"3.399","text":"I&#39;ve worked extensively in Africa,"},"515.38":{"start":"515.379","dur":"4.016","text":"with drug development scientists\nand entrepreneurs."},"519.40":{"start":"519.395","dur":"4.05","text":"I&#39;ve seen firsthand\nthe quality of their science"},"524.09":{"start":"524.09","dur":"5.881","text":"and the passion they bring to diseases\nthat affect their own local communities."},"531.55":{"start":"531.551","dur":"6.478","text":"So, selecting Africa as the first\ntarget region for a worldwide initiative"},"538.03":{"start":"538.03","dur":"1.824","text":"seemed obvious."},"540.79":{"start":"540.793","dur":"5.76","text":"In November 2015, we entered\ninto a formal partnership with ANDI,"},"546.55":{"start":"546.554","dur":"5.059","text":"the African Network for Drugs\nand Diagnostics Innovation,"},"551.61":{"start":"551.614","dur":"3.973","text":"which is a UN-based organization\nheadquartered in Addis Abeba."},"556.74":{"start":"556.744","dur":"3.229","text":"Our partnership with ANDI\nhas two components,"},"559.97":{"start":"559.974","dur":"4.918","text":"the first of which involves\nteaching African scientists"},"564.89":{"start":"564.893","dur":"5.666","text":"about the business and legal aspects\nof the bio-pharmaceutical sector,"},"570.56":{"start":"570.56","dur":"3.648","text":"helped in part by our colleagues\nhere in Geneva,"},"574.21":{"start":"574.209","dur":"3.38","text":"at the World Intellectual\nProperty Organization."},"577.59":{"start":"577.59","dur":"6.989","text":"The participants will be selected from\nthe over 40 ANDI Centres of Excellence"},"585.14":{"start":"585.138","dur":"3.223","text":"and will be taught the intricacies"},"588.36":{"start":"588.362","dur":"3.599","text":"of creating\npharmaceutical development plans,"},"591.96":{"start":"591.962","dur":"3.808","text":"as well as the intellectual property\nmanagements skills"},"595.77":{"start":"595.771","dur":"3.401","text":"needed to support those plans."},"600.27":{"start":"600.266","dur":"5.577","text":"The second component of our partnership\ninvolves the creation of regional hubs"},"605.84":{"start":"605.844","dur":"2.91","text":"distributed around Africa"},"608.76":{"start":"608.755","dur":"3.181","text":"that are modeled after DRIVE"},"611.94":{"start":"611.937","dur":"3.247","text":"and leverage ANDI&#39;s expertise"},"615.19":{"start":"615.185","dur":"3.791","text":"at promoting\nAfrican-led health innovations."},"619.82":{"start":"619.815","dur":"5.339","text":"Just like with DRIVE, each hub\nwill devote part of its attention"},"625.16":{"start":"625.155","dur":"2.174","text":"to a major market disease"},"627.33":{"start":"627.33","dur":"3.125","text":"and use revenues\nobtained from those activities"},"630.46":{"start":"630.456","dur":"3.36","text":"to subsidize research\non neglected diseases."},"634.95":{"start":"634.946","dur":"1.511","text":"Importantly,"},"637.10":{"start":"637.102","dur":"2.561","text":"since this model involves partnerships"},"639.66":{"start":"639.664","dur":"3.739","text":"between government\nand non-government agencies,"},"643.95":{"start":"643.946","dur":"3.689","text":"we can assure that drugs\nderived from this initiative"},"648.47":{"start":"648.465","dur":"4.77","text":"will be affordably priced\nand accessible to all."},"656.91":{"start":"656.91","dur":"6.702","text":"Imagine a world\nwhere important healthcare innovations"},"663.89":{"start":"663.892","dur":"5.87","text":"emerge from networks\nof focused scientists and entrepreneurs"},"671.36":{"start":"671.362","dur":"4.732","text":"operating through creative\nnon-profit structures."},"678.18":{"start":"678.182","dur":"4.881","text":"Imagine a world\nwhere today&#39;s neglected diseases"},"684.00":{"start":"684.002","dur":"2.95","text":"become tomorrow&#39;s manageable conditions;"},"686.95":{"start":"686.953","dur":"2.43","text":"just as we saw with AIDS."},"691.65":{"start":"691.65","dur":"4.863","text":"Imagine a world where companies\nthat focus on neglected diseases"},"696.51":{"start":"696.514","dur":"4.029","text":"do good and do well at the same time."},"701.51":{"start":"701.508","dur":"2.9","text":"Even better: imagine a world"},"704.41":{"start":"704.409","dur":"4.58","text":"where neglected diseases\nare things of the past."},"710.45":{"start":"710.45","dur":"1.25","text":"Thank you."},"711.70":{"start":"711.701","dur":"1.461","text":"(Applause)"}}